Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Hair follicle stem cells may cause squamous cell carcinoma due to a metabolic shift towards glycolysis.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

Somatic BHD mutations are rare in Japanese renal tumors.

Vorasidenib can cause unusual hair growth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Doxorubicin can block blood vessels from hair follicles, reducing skin tumor growth.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

LncRNAs may help improve brain cancer treatment and diagnosis.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Mutations in the SHH pathway in certain skin cells can cause skin tumors and abnormal hair growth.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.